These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34554620)

  • 1. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique.
    Okabe T; Savona SJ; Matto F; Ward C; Singh P; Afzal MR; Kalbfleisch SJ; Weiss R; Houmsse M; Augostini RS; Hummel JD; Daoud EG
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3027-3034. PubMed ID: 34554620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.
    Francia P; Biffi M; Adduci C; Ottaviano L; Migliore F; De Bonis S; Dello Russo A; De Filippo P; Viani S; Bongiorni MG; Caravati F; Lavalle C; Landolina ME; Pisanò E; Giorgi D; Lovecchio M; Valsecchi S; Diemberger I
    Europace; 2020 Dec; 22(12):1822-1829. PubMed ID: 33118017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique.
    Francia P; Adduci C; Angeletti A; Ottaviano L; Perrotta L; De Vivo S; Bongiorni MG; Migliore F; Russo AD; De Filippo P; Caravati F; Nigro G; Palmisano P; Viani S; D'Onofrio A; Lovecchio M; Valsecchi S; Ziacchi M
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1695-1703. PubMed ID: 33969578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.
    de Veld JA; Pepplinkhuizen S; van der Stuijt W; Quast ABE; Olde Nordkamp LRA; Kooiman KM; Wilde AAM; Smeding L; Knops RE
    Europace; 2023 Jul; 25(7):. PubMed ID: 37379530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 40 Joules Enough to Successfully Defibrillate With Subcutaneous Implantable Cardioverter-Defibrillators?
    Biffi M; Bongiorni MG; D'Onofrio A; Manzo M; Pieragnoli P; Palmisano P; Ottaviano L; Perego GB; Pangallo A; Lavalle C; Bonfantino V; Nigro G; Landolina ME; Katsouras G; Diemberger I; Viani S; Bianchi V; Lovecchio M; Valsecchi S; Ziacchi M;
    JACC Clin Electrophysiol; 2021 Jun; 7(6):767-776. PubMed ID: 33516714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications.
    Winter J; Siekiera M; Shin DI; Meyer C; Kröpil P; Clahsen H; O'Connor S
    Europace; 2017 Dec; 19(12):2036-2041. PubMed ID: 28007749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    Yamazaki K; Ishida Y; Sasaki S; Toyama Y; Nishizaki K; Kinjo T; Itoh T; Kimura M; Sakai S; Shikanai S; Sorimachi Y; Hamaura S; Tomita H
    J Cardiol; 2022 Nov; 80(5):482-486. PubMed ID: 35902323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    van der Stuijt W; Pepplinkhuizen S; de Veld JA; Quast ABE; van Halm VP; Bijsterveld NR; Olde Nordkamp LRA; Wilde AAM; Smeding L; Knops RE
    Int J Cardiol; 2024 Mar; 398():131639. PubMed ID: 38065323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.
    Quast ABE; Baalman SWE; Brouwer TF; Smeding L; Wilde AAM; Burke MC; Knops RE
    Heart Rhythm; 2019 Mar; 16(3):403-410. PubMed ID: 30292861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.
    Amin AK; Gold MR; Burke MC; Knight BP; Rajjoub MR; Duffy E; Husby M; Stahl WK; Weiss R
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006665. PubMed ID: 30917689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial.
    Knops RE; El-Chami MF; Marquie C; Nordbeck P; Quast ABE; Tilz RR; Brouwer TF; Lambiase PD; Cassidy CJ; Boersma LVA; Burke MC; Pepplinkhuizen S; de Veld JA; de Weger A; Bracke FALE; Manyam H; Probst V; Betts TR; Bijsterveld NR; Defaye P; Demming T; Elders J; Field DC; Ghani A; Golovchiner G; de Jong JSSG; Lewis N; Marijon E; Martin CA; Miller MA; Shaik NA; van der Stuijt W; Kuschyk J; Olde Nordkamp LRA; Arya A; Borger van der Burg AE; Boveda S; van Doorn DJ; Glikson M; Kaiser L; Maass AH; van Woerkens LJPM; Zaidi A; Wilde AAM; Smeding L
    Heart Rhythm; 2024 Jun; 21(6):836-844. PubMed ID: 38336193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?
    Frommeyer G; Zumhagen S; Dechering DG; Larbig R; Bettin M; Löher A; Köbe J; Reinke F; Eckardt L
    J Am Heart Assoc; 2016 Mar; 5(3):e003181. PubMed ID: 27068637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute human defibrillation performance of a subcutaneous implantable cardioverter-defibrillator with an additional coil electrode.
    Yap SC; Oosterwerff EFJ; Boersma LVA; van der Stuijt W; Lenssen A; Hahn SJ; Knops RE
    Heart Rhythm; 2023 Dec; 20(12):1649-1656. PubMed ID: 37579867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermuscular Two-Incision Technique for Subcutaneous Implantable Cardioverter Defibrillator Implantation: Results from a Multicenter Registry.
    Migliore F; Allocca G; Calzolari V; Crosato M; Facchin D; Daleffe E; Zecchin M; Fantinel M; Cannas S; Arancio R; Marchese P; Zanon F; Zorzi A; Iliceto S; Bertaglia E
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):278-285. PubMed ID: 27943358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Prediction of Shock Impedance for Subcutaneous Implantable Cardioverter Defibrillator Using Chest Computed Tomography.
    Kasagawa A; Nakajima I; Nakayama Y; Togashi D; Sasaki K; Matsuda H; Harada T; Akashi YJ
    Circ J; 2024 Jun; 88(7):1147-1154. PubMed ID: 38311419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing elevated subcutaneous implantable cardioverter-defibrillator defibrillation thresholds: The importance of implantation technique.
    Ip JE
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1205-1208. PubMed ID: 33484227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.